A detailed history of Lee Danner & Bass Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Lee Danner & Bass Inc holds 27,238 shares of ZTS stock, worth $4.73 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
27,238
Previous 32,446 16.05%
Holding current value
$4.73 Million
Previous $5.65 Million 4.77%
% of portfolio
0.46%
Previous 0.51%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

SELL
$151.44 - $200.09 $788,699 - $1.04 Million
-5,208 Reduced 16.05%
27,238 $5.38 Million
Q3 2023

Oct 27, 2023

SELL
$167.14 - $192.77 $4,178 - $4,819
-25 Reduced 0.08%
32,446 $5.65 Million
Q2 2023

Jul 31, 2023

SELL
$160.94 - $186.23 $65,502 - $75,795
-407 Reduced 1.24%
32,471 $5.59 Million
Q1 2023

May 02, 2023

SELL
$145.48 - $175.02 $194,215 - $233,651
-1,335 Reduced 3.9%
32,878 $5.47 Million
Q4 2022

Feb 01, 2023

SELL
$131.14 - $157.47 $65,570 - $78,735
-500 Reduced 1.44%
34,213 $5.01 Million
Q3 2022

Oct 31, 2022

SELL
$148.29 - $182.55 $210,720 - $259,403
-1,421 Reduced 3.93%
34,713 $5.15 Million
Q2 2022

Jul 25, 2022

SELL
$155.97 - $200.09 $19,496 - $25,011
-125 Reduced 0.34%
36,134 $6.21 Million
Q1 2022

Apr 27, 2022

BUY
$181.39 - $234.03 $37,003 - $47,742
204 Added 0.57%
36,259 $6.84 Million
Q4 2021

Jan 27, 2022

SELL
$193.69 - $247.03 $250,247 - $319,162
-1,292 Reduced 3.46%
36,055 $8.8 Million
Q3 2021

Nov 01, 2021

SELL
$189.29 - $209.69 $288,477 - $319,567
-1,524 Reduced 3.92%
37,347 $7.25 Million
Q2 2021

Jul 27, 2021

SELL
$155.9 - $187.99 $57,683 - $69,556
-370 Reduced 0.94%
38,871 $7.24 Million
Q1 2021

Apr 29, 2021

SELL
$144.0 - $169.39 $98,928 - $116,370
-687 Reduced 1.72%
39,241 $6.18 Million
Q4 2020

Feb 09, 2021

SELL
$157.07 - $174.35 $230,107 - $255,422
-1,465 Reduced 3.54%
39,928 $6.61 Million
Q3 2020

Nov 12, 2020

SELL
$137.1 - $165.37 $188,101 - $226,887
-1,372 Reduced 3.21%
41,393 $6.85 Million
Q2 2020

Aug 10, 2020

SELL
$111.92 - $142.53 $214,998 - $273,800
-1,921 Reduced 4.3%
42,765 $5.86 Million
Q1 2020

May 04, 2020

SELL
$92.66 - $144.94 $101,462 - $158,709
-1,095 Reduced 2.39%
44,686 $5.26 Million
Q4 2019

Feb 13, 2020

SELL
$116.25 - $133.25 $428,497 - $491,159
-3,686 Reduced 7.45%
45,781 $6.06 Million
Q3 2019

Oct 30, 2019

SELL
$112.57 - $128.43 $260,036 - $296,673
-2,310 Reduced 4.46%
49,467 $6.16 Million
Q2 2019

Jul 30, 2019

SELL
$97.98 - $114.28 $109,247 - $127,422
-1,115 Reduced 2.11%
51,777 $5.88 Million
Q1 2019

May 06, 2019

SELL
$81.56 - $100.67 $193,297 - $238,587
-2,370 Reduced 4.29%
52,892 $5.33 Million
Q4 2018

Jan 29, 2019

SELL
$79.28 - $95.27 $168,866 - $202,925
-2,130 Reduced 3.71%
55,262 $4.73 Million
Q3 2018

Nov 06, 2018

SELL
$83.5 - $93.23 $84,335 - $94,162
-1,010 Reduced 1.73%
57,392 $5.26 Million
Q2 2018

Aug 06, 2018

SELL
$79.9 - $89.2 $186,966 - $208,728
-2,340 Reduced 3.85%
58,402 $5.05 Million
Q1 2018

May 02, 2018

SELL
$71.51 - $84.69 $260,224 - $308,186
-3,639 Reduced 5.65%
60,742 $5.07 Million
Q4 2017

Feb 02, 2018

SELL
$63.24 - $72.8 $112,883 - $129,948
-1,785 Reduced 2.7%
64,381 $4.64 Million
Q3 2017

Oct 27, 2017

BUY
$59.73 - $65.4 $3.95 Million - $4.33 Million
66,166
66,166 $4.22 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Lee Danner & Bass Inc Portfolio

Follow Lee Danner & Bass Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Danner & Bass Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lee Danner & Bass Inc with notifications on news.